StonvexLoading…
StonvexStonvexStonvexCore line items from APLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $268.30M | $1.00B | $803.87M | $345.29M |
Operating Income | $26.47M | $55.43M | $106.57M | $-116.61M |
Net Income | $18.66M | $22.39M | $81.34M | $-42.15M |
EPS (Diluted) | $0.15 | $0.20 | $0.65 | $-1.07 |
Total Assets | $1.08B | $1.08B | $1.06B | $821.39M |
Total Liabilities | $667.61M | $705.11M | $657.55M | $665.09M |
Cash & Equivalents | $405.21M | $466.23M | $479.17M | $370.04M |
Free Cash Flow OCF − CapEx | Not available | $45.01M | $59.30M | $-49.02M |
Shares Outstanding | 127.92M | 126.62M | 126.50M | 126.19M |